Eva Peñas‐Lledó

3.2k total citations
78 papers, 2.1k citations indexed

About

Eva Peñas‐Lledó is a scholar working on Pharmacology, Clinical Psychology and Oncology. According to data from OpenAlex, Eva Peñas‐Lledó has authored 78 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pharmacology, 22 papers in Clinical Psychology and 14 papers in Oncology. Recurrent topics in Eva Peñas‐Lledó's work include Pharmacogenetics and Drug Metabolism (43 papers), Eating Disorders and Behaviors (18 papers) and Drug Transport and Resistance Mechanisms (13 papers). Eva Peñas‐Lledó is often cited by papers focused on Pharmacogenetics and Drug Metabolism (43 papers), Eating Disorders and Behaviors (18 papers) and Drug Transport and Resistance Mechanisms (13 papers). Eva Peñas‐Lledó collaborates with scholars based in Spain, Mexico and Brazil. Eva Peñas‐Lledó's co-authors include Adrián LLerena, Pedro Dorado, Glenn Waller, Francisco J. Vaz Leal, M.E.G. Naranjo, Fernanda Rodrigues‐Soares, Cynthia M. Bulik, Jessica H. Baker, Humberto Fariñas and Sara E. Trace and has published in prestigious journals such as Behaviour Research and Therapy, Molecular Psychiatry and Journal of Affective Disorders.

In The Last Decade

Eva Peñas‐Lledó

74 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Peñas‐Lledó Spain 25 892 708 338 312 259 78 2.1k
Akihito Suzuki Japan 25 441 0.5× 382 0.5× 900 2.7× 185 0.6× 254 1.0× 156 2.2k
Norio Yasui‐Furukori Japan 29 521 0.6× 195 0.3× 602 1.8× 465 1.5× 414 1.6× 133 2.4k
Norio Yasui‐Furukori Japan 29 498 0.6× 327 0.5× 1.5k 4.4× 354 1.1× 465 1.8× 222 3.0k
Koichi Otani Japan 31 568 0.6× 570 0.8× 1.4k 4.1× 228 0.7× 497 1.9× 204 3.5k
Norman Sussman United States 31 294 0.3× 314 0.4× 464 1.4× 97 0.3× 142 0.5× 112 3.5k
Chad Bousman Australia 38 975 1.1× 463 0.7× 1.1k 3.1× 179 0.6× 561 2.2× 188 4.4k
Mario Palermo Italy 26 225 0.3× 327 0.5× 275 0.8× 116 0.4× 139 0.5× 59 2.1k
Tsuyoshi Kondo Japan 30 507 0.6× 225 0.3× 1.4k 4.2× 229 0.7× 613 2.4× 158 2.6k
L. DiAnne Bradford United States 16 1.3k 1.5× 111 0.2× 274 0.8× 510 1.6× 370 1.4× 24 2.2k
Vicki L. Ellingrod United States 30 354 0.4× 245 0.3× 1.2k 3.6× 207 0.7× 371 1.4× 131 3.1k

Countries citing papers authored by Eva Peñas‐Lledó

Since Specialization
Citations

This map shows the geographic impact of Eva Peñas‐Lledó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Peñas‐Lledó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Peñas‐Lledó more than expected).

Fields of papers citing papers by Eva Peñas‐Lledó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Peñas‐Lledó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Peñas‐Lledó. The network helps show where Eva Peñas‐Lledó may publish in the future.

Co-authorship network of co-authors of Eva Peñas‐Lledó

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Peñas‐Lledó. A scholar is included among the top collaborators of Eva Peñas‐Lledó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Peñas‐Lledó. Eva Peñas‐Lledó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rodrigues‐Soares, Fernanda, et al.. (2024). The Frequency of DPYD c.557A>G in the Dominican Population and Its Association with African Ancestry. Pharmaceutics. 17(1). 8–8.
3.
Rodrigues‐Soares, Fernanda, et al.. (2024). Afro-Latin American Pharmacogenetics of CYP2D6, CYP2C9, and CYP2C19 in Dominicans: A Study from the RIBEF-CEIBA Consortium. Pharmaceutics. 16(11). 1399–1399. 4 indexed citations
4.
Fricke-Galindo, Ingrid, Helgi Jung–Cook, Iris E. Martínez‐Juárez, et al.. (2021). Relevance of NR1I2 Variants on Carbamazepine Therapy in Mexican Mestizos with Epilepsy at a Tertiary-Care Hospital. Pharmacogenomics. 22(15). 983–996.
5.
Andrés, Fernando de, et al.. (2020). Relationships between CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 metabolic phenotypes and genotypes in a Nicaraguan Mestizo population. The Pharmacogenomics Journal. 21(2). 140–151. 20 indexed citations
6.
Fricke-Galindo, Ingrid, M.E.G. Naranjo, Fernanda Rodrigues‐Soares, et al.. (2015). Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes. Expert Opinion on Drug Metabolism & Toxicology. 11(12). 1893–1905. 47 indexed citations
7.
Peñas‐Lledó, Eva, et al.. (2014). Liver enzyme abnormalities during antipsychotic treatment: a case report of risperidone-associated hepatotoxicity. Drug metabolism and drug interactions. 29(2). 123–126. 7 indexed citations
8.
Peñas‐Lledó, Eva, Sébastien Guillaume, M.E.G. Naranjo, et al.. (2014). A combined high CYP2D6-CYP2C19 metabolic capacity is associated with the severity of suicide attempt as measured by objective circumstances. The Pharmacogenomics Journal. 15(2). 172–176. 22 indexed citations
9.
LLerena, Adrián, M.E.G. Naranjo, Fernanda Rodrigues‐Soares, et al.. (2014). Interethnic variability ofCYP2D6alleles and of predicted and measured metabolic phenotypes across world populations. Expert Opinion on Drug Metabolism & Toxicology. 10(11). 1569–1583. 121 indexed citations
10.
Dorado, Pedro, et al.. (2013). MDR-1 genotypes and quetiapine pharmacokinetics in healthy volunteers. Drug metabolism and drug interactions. 28(3). 163–166. 10 indexed citations
11.
Dorado, Pedro, et al.. (2012). Development of a HPLC method for the determination of losartan urinary metabolic ratio to be used for the determination of CYP2C9 hydroxylation phenotypes. Drug metabolism and drug interactions. 27(4). 217–223. 4 indexed citations
12.
Dorado, Pedro, Fernando de Andrés, M.E.G. Naranjo, et al.. (2012). High-performance liquid chromatography method using ultraviolet detection for the quantification of aripiprazole and dehydroaripiprazole in psychiatric patients. Drug metabolism and drug interactions. 27(3). 165–170. 4 indexed citations
13.
Dorado, Pedro, et al.. (2012). Neurological toxicity after phenytoin infusion in a pediatric patient with epilepsy: influence of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms. The Pharmacogenomics Journal. 13(4). 359–361. 29 indexed citations
14.
Dorado, Pedro, Martha Sosa‐Macías, Eva Peñas‐Lledó, et al.. (2010). CYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and Spaniards. The Pharmacogenomics Journal. 11(2). 108–112. 37 indexed citations
15.
Peñas‐Lledó, Eva, Susana Jiménez‐Múrcia, Roser Granero, et al.. (2010). Specific eating disorder clusters based on social anxiety and novelty seeking. Journal of Anxiety Disorders. 24(7). 767–773. 24 indexed citations
16.
LLerena, Adrián, et al.. (2010). CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans. The Pharmacogenomics Journal. 12(2). 176–183. 53 indexed citations
17.
Dorado, Pedro, et al.. (2007). Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5‐HTTLPR‐S) and the CYP2C9*3 allele. Fundamental and Clinical Pharmacology. 21(4). 451–453. 29 indexed citations
18.
Cáceres, Macarena C., Eva Peñas‐Lledó, Alfredo de la Rubia, & Adrián LLerena. (2007). Increased use of second generation antipsychotic drugs in primary care: potential relevance for hospitalizations in schizophrenia patients. European Journal of Clinical Pharmacology. 64(1). 73–76. 12 indexed citations
19.
LLerena, Adrián, Alfredo de la Rubia, Eva Peñas‐Lledó, Francisco J. Díaz, & José de León. (2003). Schizophrenia and tobacco smoking in a Spanish psychiatric hospital. Schizophrenia Research. 60(2-3). 313–317. 33 indexed citations
20.
Peñas‐Lledó, Eva, Francisco J. Vaz Leal, & Glenn Waller. (2002). Excessive exercise in anorexia nervosa and bulimia nervosa: Relation to eating characteristics and general psychopathology. International Journal of Eating Disorders. 31(4). 370–375. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akihito Suzuki Breakdown of academic impact, for papers by Norio Yasui‐Furukori Breakdown of academic impact, for papers by Norio Yasui‐Furukori Breakdown of academic impact, for papers by Koichi Otani Breakdown of academic impact, for papers by Norman Sussman Breakdown of academic impact, for papers by Chad Bousman Breakdown of academic impact, for papers by Mario Palermo Breakdown of academic impact, for papers by Tsuyoshi Kondo Breakdown of academic impact, for papers by L. DiAnne Bradford Breakdown of academic impact, for papers by Vicki L. Ellingrod
Rankless by CCL
2026